Treatment of NMO relapse in the elderly: rituximab when plasma exchange fails?
Author:
Publisher
Springer Science and Business Media LLC
Subject
Clinical Neurology,General Medicine
Link
http://link.springer.com/content/pdf/10.1007/s13760-013-0178-6.pdf
Reference5 articles.
1. Lefaucheur R, Bourre B, Ahtoy P, Ozkul O, Tollard E, Hannequin D et al (2011) Neuromyelitis optica with very late onset. J Am Geriatr Soc 59(6):1138–1140
2. Kim SH, Kim W, Li XF, Jung IJ, Kim HJ (2011) Repeated treatment with rituximab based on the assessment of peripheral circulating memory B cells in patients with relapsing neuromyelitis optica over 2 years. Arch Neurol 68(11):1412–1420
3. Sellner J, Boggild M, Clanet M, Hintzen RQ, Illes Z, Montalban X et al (2010) EFNS guidelines on diagnosis and management of neuromyelitis optica. Eur J Neurol 17(8):1019–1032
4. Basic-Jukic N, Brunetta B, Kes P (2010) Plasma exchange in elderly patients. Ther Apher Dial. 14(2):161–165
5. Abdel-Rahman EM, Hayes J, Balogun RA (2012) Therapeutic plasma exchange in the elderly: experience at a tertiary center. J Clin Apher. 27(3):108–111
Cited by 5 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. MECHANISM OF RITUXIMAB IN THE TREATMENT OF NEUROMYELITIS OPTICA;FARMACIA;2022-06-26
2. Disease course, progression and activity of neuromyelitis optica (NMOSD) in patients who were treated with Rituximab, 6 and 12 months after receiving the first dose of drug, in Isfahan city;Multiple Sclerosis and Related Disorders;2019-09
3. Efficacy and safety of rituximab in neuromyelitis optica: Review of evidence;Journal of Research in Medical Sciences;2017
4. Efficacy and Safety of Rituximab Therapy in Neuromyelitis Optica Spectrum Disorders;JAMA Neurology;2016-11-01
5. Very late-onset neuromyelitis optica spectrum disorder beyond the age of 75;Journal of Neurology;2015-05
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3